Carlyle’s Investment in MAK-System
February 18, 2020
Cleary Gottlieb represented the Kiskovski family, as the shareholders of global blood management solutions software provider MAK-System, in the significant investment by The Carlyle Group (Carlyle) in MAK-System.
The transaction signed on January 16, 2020, after an auction process, and closed on February 18, 2020.
The investment comes from Carlyle Europe Partners V (CEP V), a European-focused upper-mid market buyout fund, as well as from Carlyle Europe Technology Partners IV (CETP IV), a pan-European and U.S. fund focusing on growth-oriented investments in telecoms, media, and technology.
Founded in 1984 by the Kiskovski family, MAK-System is a leading provider of state-of-the-art software solutions supporting the entire blood chain management process, from donation through to transfusion. It has operations in more than 65 continents and is considered a preeminent blood management software expert.